Cite

HARVARD Citation

    Bazarbachi, A. et al. (2018). Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party. British journal of haematology. pp. 86-96. [Online]. 
  
Back to record